X-linked agammaglobulinemia

Request an Appointment
Print

Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Departments that treat this condition

Research

At Mayo Clinic's Minnesota campus, doctors in the Primary Immunodeficiency Center conduct research on XLA and other primary immunodeficiency conditions.

Researchers and doctors trained in immune system disorders, genetics and other conditions conduct basic and clinical research aimed at developing new treatments for XLA. Treatments under study include stem cell transplantation and gene therapy.

Publications

See a list of publications about X-linked agammaglobulinemia by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

Research Profiles

Edit search filters
close

Narrow your search

View all physicians • All Locations

By Mayo Clinic Staff

X-linked agammaglobulinemia care at Mayo Clinic

Request an appointment
Diagnosis & treatmentCare at Mayo Clinic
Jan. 10, 2024
Print

Living with x-linked agammaglobulinemia?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

hikerny
Anyone have chronic lymphocytic leukemia (CLL)?

277 Replies Tue, May 12, 2026

sandramgus
Diagnosed: MGUS

182 Replies Sun, May 10, 2026

eddb
Anyone else find the side effects of Hydrea 500MG frightening?

171 Replies Sun, May 10, 2026

See more discussions

Related

Products & Services

X-linked agammaglobulinemia

Research: It's all about patients

[MUSIC PLAYING]

Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care. So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes right — and let's say it's helpful or beneficial — then brought on as a standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to put it in its own spotlight.